IDEXX Laboratories Inc. Stock Performance
IDEXX Laboratories Inc., a healthcare equipment and supply company, has experienced a decline in its stock price over the past few years. The company’s shares have lost value since an investment three years ago, resulting in a negative performance of approximately 28.58%.
Market Capitalization and Share Value
The stock’s value has decreased, and the company’s market capitalization has also decreased. This decline has led to investor concerns and speculation about the company’s future prospects.
Industry Presence and Expertise
IDEXX Laboratories has a strong presence in the animal health industry, with products used globally. The company’s expertise and talent pool in the industry are evident in the appointment of a new Chief Financial Officer from IDEXX Laboratories to ImmuCell Corporation, a rival company.
Key Facts
- Negative stock performance: 28.58% over the past three years
- Decrease in market capitalization
- Appointment of new Chief Financial Officer from IDEXX Laboratories to ImmuCell Corporation